Atovaquone
Mepron and generics
Antiprotozoal
| C | 3 | Yes | Yes | No |
| Key |
- Oral suspension: 750 mg/5 mL (210 mL); contains benzyl alcohol
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Hughes, Helen K., and Lauren K. Kahl, editors. "Atovaquone." Harriet Lane Handbook, 23rd ed., Elsevier, 2024. Harriet Lane, www.unboundmedicine.com/harrietlane/view/Harriet_Lane_Handbook/309270/2/Atovaquone.
Atovaquone. In: Hughes HKH, Kahl LKL, eds. Harriet Lane Handbook. Elsevier; 2024. https://www.unboundmedicine.com/harrietlane/view/Harriet_Lane_Handbook/309270/2/Atovaquone. Accessed April 22, 2026.
Atovaquone. (2024). In Hughes, H. K., & Kahl, L. K. (Eds.), Harriet Lane Handbook (23rd ed.). Elsevier. https://www.unboundmedicine.com/harrietlane/view/Harriet_Lane_Handbook/309270/2/Atovaquone
Atovaquone [Internet]. In: Hughes HKH, Kahl LKL, editors. Harriet Lane Handbook. Elsevier; 2024. [cited 2026 April 22]. Available from: https://www.unboundmedicine.com/harrietlane/view/Harriet_Lane_Handbook/309270/2/Atovaquone.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Atovaquone
ID - 309270
ED - Hughes,Helen K,
ED - Kahl,Lauren K,
BT - Harriet Lane Handbook
UR - https://www.unboundmedicine.com/harrietlane/view/Harriet_Lane_Handbook/309270/2/Atovaquone
PB - Elsevier
ET - 23
DB - Harriet Lane
DP - Unbound Medicine
ER -

Harriet Lane Handbook

